Source link : https://newshealth.biz/health-news/off-label-drug-proves-its-mettle-in-relapsing-multiple-sclerosis/
(MedPage Today) — Off-label rituximab was noninferior to ocrelizumab (Ocrevus) in people with newly diagnosed relapsing multiple sclerosis (MS) and recent disease activity, the phase III OVERLORD-MS trial showed. At 2 years, the estimated probability… Source link : https://www.medpagetoday.com/neurology/multiplesclerosis/122021 Author : Publish date : 2026-07-01 21:26:00 Copyright for syndicated content belongs to the linked Source.
The post Off-Label Drug Proves Its Mettle in Relapsing Multiple Sclerosis first appeared on News Health.
—-
Author : News Health
Publish date : 2026-07-01 21:26:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8